Accelerate Diagnostics Inc Preço/Valor Contábil
Qual é o Preço/Valor Contábil de Accelerate Diagnostics Inc?
O Preço/Valor Contábil de Accelerate Diagnostics Inc é -2.27
Qual é a definição de Preço/Valor Contábil?
A razão entre cotação e valor contabilístico representa a razão entre o valor das ações de uma empresa e o valor contábil por ação.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Preço/Valor Contábil de empresas na Setor Health Care em NASDAQ em comparação com Accelerate Diagnostics Inc
O que Accelerate Diagnostics Inc faz?
accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.
Empresas com preço/valor contábil semelhantes a Accelerate Diagnostics Inc
- Aquis Entertainment tem Preço/Valor Contábil de -2.31
- Zelira Therapeutics tem Preço/Valor Contábil de -2.30
- Infinity Pharmaceuticals tem Preço/Valor Contábil de -2.29
- Acreage tem Preço/Valor Contábil de -2.28
- CytomX Therapeutics Inc tem Preço/Valor Contábil de -2.28
- Holista CollTech tem Preço/Valor Contábil de -2.27
- Accelerate Diagnostics Inc tem Preço/Valor Contábil de -2.27
- Bridgemarq Real Estate Services tem Preço/Valor Contábil de -2.27
- Biophytis SA tem Preço/Valor Contábil de -2.25
- Optiva tem Preço/Valor Contábil de -2.25
- Calumet tem Preço/Valor Contábil de -2.25
- Excellon Resources tem Preço/Valor Contábil de -2.25
- AA Plc tem Preço/Valor Contábil de -2.24